1. Abbvie Deutschland Gmbh and Co Kg (29 from 167 patents)

2. Abbvie Inc. (17 from 822 patents)

3. Abbott Gmbh & Co Kg (16 from 139 patents)

4. Basf Aktiengesellschaft (14 from 10,754 patents)

5. Abbott Laboratories Corporation (10 from 4,179 patents)

6. Basf Aktienegesellschaft (1 from 5 patents)

1. 10556907 - Fused heterocyclic compounds as S1P modulators

2. 10280159 - Fused (hetero)cyclic compounds as S1P modulators

3. 9656955 - Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

4. 9650334 - Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

5. 9586945 - Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy

6. 9586942 - Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

7. 9550754 - 4,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapy

8. 9475782 - Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors

9. 9365512 - Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy

10. 9309200 - Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy

11. 9296697 - [object Object]

12. 9242933 - Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)

13. 9238619 - Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

14. 9227930 - Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

15. 9096619 - Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy